FIELD: medicine.
SUBSTANCE: what is described is a diagnostic technique for deletions and duplications of PARK2 gene exons involving simultaneous amplification of one of park gene exons and a tracking gene in test samples of human genome DNA by real-time polymerase chain reaction with using exon-flanking outer primers and located between primers of fluorescent-marked hybridisation probes where polymerase chain reaction is four-staged in the following conditions: a reaction mixture is heated at temperature 50°C for 2 minutes, denatured at 95°C for 15 minutes, denatured at 95°C for 15 seconds, incubated at 61°C for 45 seconds; 35 cycles are repeated consistently with the two last stages; the absence of deletions, the presence of heterozygotic or homozygous deletions or the presence of duplications of exon is stated by the coefficient R which is calculated by formula R=2-(ΔCt), where ΔCt = [Ct tracking gene (reference DNA) - Ct park (reference DNA)] - [Ct tracking gene (patient's DNA sample)-Ct park PARK2 (patient's DNA sample)].
EFFECT: invention allows detecting mutations in PARK2 gene.
14 cl, 5 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR IDENTIFICATION OF GENETIC MARKERS OF LATER FORM OF PARKINSON DISEASE | 2013 |
|
RU2663908C1 |
SET OF SPECIFIC HYBRIDIZATION PROBES FOR DETERMINATION OF CHANGES IN HUMAN LYSOSOME-ASSOCIATED PROTEIN-2 (LAMP2) GENE BY MLPA METHOD FOR DIAGNOSTICS OF DANONE'S DISEASE | 2021 |
|
RU2781084C1 |
MOLECULAR GENETIC METHOD OF TUMOUR SENSITIVITY TEST IN PATIENTS WITH LUNG CANCER TO GEFITINIB THERAPY | 2010 |
|
RU2454464C2 |
METHOD OF DIAGNOSING MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME | 2022 |
|
RU2798695C1 |
METHOD FOR HUMAN GENOTYPE DETERMINATION BY 185 GENE BRCA1 (185delAG) POSITION POLYMORPHISM | 2010 |
|
RU2445369C2 |
METHOD FOR HUMAN GENOTYPE DETERMINATION BY 6174 GENE BRCA2 (617delT) POSITION POLYMORPHISM | 2010 |
|
RU2445372C1 |
METHOD OF PROGNOSTIC ASSESSMENT OF HEPATOTOXICITY IN HIV-INFECTED PATIENTS DURING ANTIRETROVIRAL THERAPY BASED ON THE DETERMINATION OF DELETION POLYMORPHISM OF GSTM1, GSTT1, CYP2D6 HUMAN XENOBIOTIC BIOTRANSFORMATION GENES AND A SET OF OLIGODEOXYRIBONUCLEOTIDE PRIMERS AND FLUORESCENTLY LABELED PROBES | 2022 |
|
RU2807530C1 |
METHOD FOR DETERMINING PULMONARY TUMOUR SENSITIVITY TO TYROSINE KINASE INHIBITOR THERAPY | 2012 |
|
RU2499994C1 |
METHOD FOR DIAGNOSING VARIANT SOPH c.5741G>A IN NBAS GENE | 2024 |
|
RU2819985C1 |
MOLECULAR GENETIC SYSTEM FOR DETECTION OF DELETION SMN1 EXON 7 SUITABLE FOR NEONATAL SCREENING | 2021 |
|
RU2796350C1 |
Authors
Dates
2011-09-10—Published
2010-05-31—Filed